Financing, Equity Capital Markets

Keros Therapeutics

11/20
|
$149.5 Million
Piper Sandler served as bookrunner for Keros Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma